Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Dominant mutations in ubiquitously expressed superoxide dismutase (SOD1) cause familial ALS by provoking premature death of adult motor neurons. To test whether mutant damage to cell types beyond motor neurons is required for the onset of motor neuron disease, we generated chimeric mice in which all motor neurons and oligodendrocytes expressed mutant SOD1 at a level sufficient to cause fatal, early-onset motor neuron disease when expressed ubiquitously, but did so in a cellular environment containing variable numbers of non-mutant, non-motor neurons. Despite high-level mutant expression within 100% of motor neurons and oligodendrocytes, in most of these chimeras, the presence of WT non-motor neurons substantially delayed onset of motor neuron degeneration, increasing disease-free life by 50%. Disease onset is therefore non-cell autonomous, and mutant SOD1 damage within cell types other than motor neurons and oligodendrocytes is a central contributor to initiation of motor neuron degeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies in disease models have shown that mutations in SOD1 associated with amyotrophic lateral sclerosis affect not only motor neurons, but also non-neuronal cells in ways that promote neurodegeneration8”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [8]
Citations
Cites
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
Self-citationWong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,445
Self-citationALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Vande Velde, C., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,429
Self-citationBruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341 · cited 1×
“Motor neuron disease from expression of mutant SOD1 has previously been demonstrated to arise from loss of the pool of large caliber motor axons (21), including for end-stage mutant SOD1G37R (22) (see also Fig.”
BackgroundSelf-citationAstrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., & Przedborski, S. (2007) · Nature Neuroscience · doi:10.1038/nn1876 · Cited by 1,220
UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS
Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144244 · Cited by 1,185
Self-citationAstrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., Takahashi, R., Misawa, H., & Cleveland, D. W. (2008) · Nature Neuroscience · doi:10.1038/nn2047 · Cited by 1,140 · cited 6×
“Thus, although the number of Olig / ::SOD1G37R chimeric mice produced for this study was relatively small because of the complexity of the experimental design, our data establish that onset of motor neuron degeneration is non-cell autonomous and that non-autonomous cell contributors to onset may be distinguishable fro…”
BackgroundInfluentialSelf-citationMolecular biology of amyotrophic lateral sclerosis: insights from genetics
Pasinelli, P., & Brown, R. H. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1971 · Cited by 1,107
Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W., Siwek, D., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,100
Self-citationLu, Q. R., Sun, T., Zhu, Z., Ma, N., Garcia, M., Stiles, C. D., & Rowitch, D. H. (2002) · Cell · doi:10.1016/s0092-8674(02)00678-5 · Cited by 1,073
Self-citation
Cited by
Items 101–200 of 376
Motor neuron–immune interactions: the vicious circle of ALS
Barbeito, A. G., Mesci, P., & Boillée, S. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0429-0 · Cited by 63
Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis
Tovar-y-Romo, L. B., Santa-Cruz, L. D., & Tapia, R. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-31 · Cited by 52
Mortal engines: Mitochondrial bioenergetics and dysfunction in neurodegenerative diseases
Joshi, A. U., & Mochly‐Rosen, D. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.010 · Cited by 58
Mimoto, T., Miyazaki, K., Morimoto, N., Kurata, T., Satoh, K., Ikeda, Y., & Abe, K. (2012) · Brain Research · doi:10.1016/j.brainres.2011.12.064 · Cited by 57
Stem Cell-Derived Motor Neurons: Applications and Challenges in Amyotrophic Lateral Sclerosis
Thonhoff, J. R., Ojeda, L. D., & Wu, P. (2009) · Current Stem Cell Research & Therapy · doi:10.2174/157488809789057392 · Cited by 56
Research Advances in Amyotrophic Lateral Sclerosis, 2009 to 2010
Traub, R., Mitsumoto, H., & Rowland, L. P. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0160-0 · Cited by 55
Revisiting the role of the innate immune complement system in ALS
Parker, S. E., Hanton, A. M., Stefanou, S. N., Noakes, P. G., Woodruff, T. M., & Lee, J. D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.003 · Cited by 55
Relationship between neuropathology and disease progression in the SOD1G93A ALS mouse
Yang, W. W., Sidman, R. L., Taksir, T. V., Treleaven, C. M., Fidler, J. A., Cheng, S. H., Dodge, J. C., & Shihabuddin, L. S. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.11.019 · Cited by 54
The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis
Cox, L. M., Calcagno, N., Gauthier, C., Madore, C., Butovsky, O., & Weiner, H. L. (2022) · Microbiome · doi:10.1186/s40168-022-01232-z · Cited by 53
“Modulating levels of mutant SOD1 in motor neurons affects disease onset and the earlier stages of disease [18, 26] whereas selectively silencing mutant SOD1 in microglia delays motor neuron degeneration and extends survival [13].”
BackgroundDibaj, P., Zschüntzsch, J., Steffens, H., Scheffel, J., Göricke, B., Weishaupt, J. H., Meur, K. L., Kirchhoff, F., Hanisch, U., Schomburg, E. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043963 · Cited by 53
Amyotrophic lateral sclerosis: The complement and inflammatory hypothesis
Kjældgaard, A.-L., Pilely, K., Olsen, K. S., Pedersen, S. W., Lauritsen, A. Ø., Møller, K., & Garred, P. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.007 · Cited by 53
Bakavayev, S., Chetrit, N., Zvagelsky, T., Mansour, R. E., Vyazmensky, M., Barak, Z., Israelson, A., & Engel, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-47326-x · Cited by 53
Saini, A., & Chawla, P. A. (2023) · European Journal of Neurology · doi:10.1111/ene.16140 · Cited by 52
Lenzi, J., Pagani, F., Santis, R. D., Limatola, C., Bozzoni, I., Angelantonio, S. D., & Rosa, A. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.06.003 · Cited by 52
Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1
Sargsyan, S. A., Blackburn, D. J., Barber, S. C., Monk, P. N., & Shaw, P. J. (2009) · Neuroreport · doi:10.1097/wnr.0b013e328331e8fa · Cited by 51
Azam, S., Haque, M. E., Kim, I., & Choi, D. (2021) · Cells · doi:10.3390/cells10010150 · Cited by 51
The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis
Pikatza‐Menoio, O., Elicegui, A., Bengoetxea, X., Naldaiz‐Gastesi, N., de Munaín, A. L., Gereñu, G., Gil-Bea, F. J., & Alonso‐Martín, S. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070671 · Cited by 51
Targeting angiogenin in therapy of amyotropic lateral sclerosis
Kishikawa, H., Wu, D., & Hu, G.-F. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.10.1229 · Cited by 52
Advances in stem cell therapy for amyotrophic lateral sclerosis
Mazzini, L., Ferrari, D., Anđjus, P. R., Bużańska, L., Cantello, R. M., Marchi, F. D., Gelati, M., Giniatullin, R. A., Glover, J. C., Grilli, M., et al. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1503248 · Cited by 50
Mitsui, S., Otomo, A., Nozaki, M., Ono, S., Sato, K., Shirakawa, R., Adachi, H., Aoki, M., Sobue, G., Shang, H., et al. (2018) · Molecular Brain · doi:10.1186/s13041-018-0373-8 · Cited by 49
Massenzio, F., Peña‐Altamira, E., Petralla, S., Virgili, M., Zuccheri, G., Miti, A., Polazzi, E., Mengoni, I., Piffaretti, D., & Monti, B. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.013 · Cited by 49
Christoforidou, E., Joilin, G., & Hafezparast, M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01822-4 · Cited by 48
ALS: Focus on purinergic signalling
Volonté, C., Apolloni, S., Carrì, M. T., & D’Ambrosi, N. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.002 · Cited by 48
Mutant UBQLN2P497H in motor neurons leads to ALS-like phenotypes and defective autophagy in rats
Chen, T., Huang, B., Shi, X., Gao, L., & Huang, C. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0627-9 · Cited by 47
Mitochondrial Transport and Turnover in the Pathogenesis of Amyotrophic Lateral Sclerosis
Granatiero, V., & Manfredi, G. (2019) · Biology · doi:10.3390/biology8020036 · Cited by 47
Fujioka, Y., Ishigaki, S., Masuda, A., Iguchi, Y., Udagawa, T., Watanabe, H., Katsuno, M., Ohno, K., & Sobue, G. (2013) · Scientific Reports · doi:10.1038/srep02388 · Cited by 46
Ablation of Keratan Sulfate Accelerates Early Phase Pathogenesis of ALS
Hirano, K., Ohgomori, T., Kobayashi, K., Tanaka, F., Matsumoto, T., Natori, T., Matsuyama, Y., Uchimura, K., Sakamoto, K., Takeuchi, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066969 · Cited by 46
Lin, P.-Y., Simon, S. M., Koh, W. K., Folorunso, O. O., Umbaugh, C. S., & Pierce, A. P. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-43 · Cited by 46
Significance of aberrant glial cell phenotypes in pathophysiology of amyotrophic lateral sclerosis
Trías, E., Ibarburu, S., Barreto‐Núñez, R., & Barbeito, L. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.07.052 · Cited by 46
Held, A., Major, P., Şahin, A., Reenan, R. A., Lipscombe, D., & Wharton, K. A. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1771-18.2019 · Cited by 46
MicroRNAs: Newcomers into the ALS Picture
Volonte, C., Apolloni, S., & Parisi, C. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150116125506 · Cited by 42
Kaus, A. S., & Sareen, D. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00448 · Cited by 45
Zalfa, C., Nodari, L. R., Vacchi, E., Gelati, M., Profico, D. C., Boido, M., Binda, E., Filippis, L. D., Copetti, M., Garlatti, V., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1582-5 · Cited by 45
Serrano, A., Donno, C., Giannetti, S., Perić, M., Andjus, P., D’Ambrosi, N., & Michetti, F. (2017) · Mediators of Inflammation · doi:10.1155/2017/1626204 · Cited by 39
Where and Why Modeling Amyotrophic Lateral Sclerosis
Liguori, F., Amadio, S., & Volonté, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083977 · Cited by 44
Kim, S., Chung, A., Na, J. E., Lee, S. J., Jeong, S. H., Kim, E., Sun, W., Rhyu, I. J., & Park, H. (2019) · Glia · doi:10.1002/glia.23669 · Cited by 43
Gut microbiota immune cross-talk in amyotrophic lateral sclerosis
Kaul, M., Mukherjee, D., Weiner, H. L., & Cox, L. M. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00469 · Cited by 42
Neuropharmacology of Organoselenium Compounds in Mental Disorders and Degenerative Diseases
Birmann, P. T., Casaril, A. M., Abenante, L., Penteado, F., Brüning, C. A., Savegnago, L., & Lenardao, E. J. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220615124412 · Cited by 42
Signaling Pathways Controlling Neural Stem Cells Slow Progressive Brain Disease
Androutsellis‐Theotokis, A., Rueger, M. A., Mkhikian, H., Korb, E., & McKay, R. D. G. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.018 · Cited by 42
von Grabowiecki, Y., Abreu, P., Blanchard, O., Palamiuc, L., Benosman, S., Mériaux, S. B., Devignot, V., Groß, I., Mellitzer, G., de Aguilar, J. G., et al. (2016) · eLife · doi:10.7554/elife.10528 · Cited by 40
Genetic validation of a therapeutic target in a mouse model of ALS
de Boer, A. S., Koszka, K., Kiskinis, E., Suzuki, N., Davis‐Dusenbery, B. N., & Eggan, K. C. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009351 · Cited by 38
Datta, I., Ganapathy, K., Razdan, R., & Bhonde, R. R. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0767-0 · Cited by 38
Koza, L. A., Winter, A. N., Holsopple, J., Baybayon-Grandgeorge, A. N., Peña, C., Olson, J. R., Mazzarino, R. C., Patterson, D., & Linseman, D. A. (2020) · Nutrients · doi:10.3390/nu12061824 · Cited by 37
Technologies for Targeted RNA Degradation and Induced RNA Decay
Mikutis, S., & Bernardes, G. J. L. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00472 · Cited by 36
Ganz, J., Arie, I., Ben‐Zur, T., Dadon-Nachum, M., Pour, S., Araidy, S., Pitaru, S., & Offen, D. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0074 · Cited by 36
Sannigrahi, A., Chowdhury, S., Das, B., Banerjee, A., Halder, A., Kumar, A., Saleem, M., Naganathan, A. N., Karmakar, S., & Chattopadhyay, K. (2021) · eLife · doi:10.7554/elife.61453 · Cited by 36
Neurodegenerative disease-specific induced pluripotent stem cell research
Inoue, H. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.022 · Cited by 36
What skeletal muscle has to say in amyotrophic lateral sclerosis: Implications for therapy
Manzano, R., Toivonen, J. M., Moreno‐Martínez, L., de la Torre, M., Moreno‐García, L., López‐Royo, T., Molina, N., Zaragoza, P., Calvo, A. C., & Osta, R. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15276 · Cited by 35
Díaz‐Amarilla, P., Miquel, E., Trostchansky, A., Trías, E., Ferreira, A. M., Freeman, B. Α., Cassina, P., Barbeito, L., Vargas, M. R., & Rubbo, H. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.03.013 · Cited by 35
Phenotypic heterogeneity of astrocytes in motor neuron disease
Trias, E., Barbeito, L., & Yamanaka, K. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12476 · Cited by 30
Self-citationZhang, P., Haidet‐Phillips, A. M., Pham, J. T., Lee, Y., Huo, Y., Tienari, P. J., Maragakis, N. J., Sattler, R., & Rothstein, J. D. (2016) · Glia · doi:10.1002/glia.22903 · Cited by 32
Will Stem Cell Biology Generate New Therapies for Parkinson's Disease?
McKay, R. D. G., & Kittappa, R. (2008) · Neuron · doi:10.1016/j.neuron.2008.05.016 · Cited by 32
Metalloproteinase alterations in the bone marrow of ALS patients
Bossolasco, P., Cova, L., Calzarossa, C., Servida, F., Mencacci, N. E., Onida, F., Polli, E. E., Deliliers, G. L., & Silani, V. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0584-7 · Cited by 32
Barclay, S. S., Tamura, T., Ito, H., Fujita, K., Tagawa, K., Shimamura, T., Katsuta, A., Shiwaku, H., Sone, M., Imoto, S., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt524 · Cited by 32
Tamura, T., Sone, M., Yamashita, M., Wanker, E. E., & Okazawa, H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004262 · Cited by 32
Duranti, E., & Villa, C. (2023) · Biomolecules · doi:10.3390/biom13111582 · Cited by 31
Advances in Cellular Models to Explore the Pathophysiology of Amyotrophic Lateral Sclerosis
Veyrat‐Durebex, C., Corcia, P., Dangoumau, A., Laumonnier, F., Piver, É., Gordon, P. H., Andres, C. R., Vourc’h, P., & Blasco, H. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8573-9 · Cited by 31
Solomonov, Y., Hadad, N., & Lévy, R. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0602-y · Cited by 30
Hernández, S., Casanovas, A., Piedrafita, L., Tarabal, O., & Esquerda, J. E. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181cd3e33 · Cited by 29
Hilton, J. B. W., Kysenius, K., White, A. R., & Crouch, P. J. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.06.006 · Cited by 28
Marton, S., Miquel, E., Acosta-Rodríguez, J., Fontenla, S., Libisch, G., & Cassina, P. (2023) · ASN NEURO · doi:10.1177/17590914231197527 · Cited by 27
Brain–body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis
Jacob, S. M., Lee, S., Kim, S. H., Sharkey, K. A., Pfeffer, G., & Nguyen, M. D. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00991-7 · Cited by 27
PTEN regulates AMPA receptor-mediated cell viability in iPS-derived motor neurons
Yang, D., Wang, X.-L., Ismail, A., Ashman, C. J., Valori, C. F., Wang, G., Gao, S., Higginbottom, A., Ince, P. G., Azzouz, M., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.55 · Cited by 27
El‐Kadi, A. M., Bros‐Facer, V., Deng, W., Philpott, A., Stoddart, E., Banks, G. T., Jackson, G. S., Fisher, E., Duchen, M. R., Greensmith, L., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.129320 · Cited by 27
Audet, J.-N., Gowing, G., Paradis, R., Soucy, G., & Julien, J.-P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034932 · Cited by 21
Wada, T., Goparaju, S. K., Tooi, N., Inoue, H., Takahashi, R., Nakatsuji, N., & Aiba, K. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0061 · Cited by 26
Yin, X. L., Wang, S., Qi, Y., Wang, X., Jiang, H., Wang, T., Yang, Y., Wang, Y., Zhang, C., & Feng, H. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.05.004 · Cited by 25
Asveda, T., Talwar, P., & Ravanan, P. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121920 · Cited by 24
Dibaj, P., Steffens, H., Zschüntzsch, J., Kirchhoff, F., Schomburg, E. D., & Neusch, C. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.04.049 · Cited by 22
Respiratory dysfunction in a mouse model of spinocerebellar ataxia type 7
Fusco, A. F., Pucci, L. A., Switonski, P. M., Biswas, D. D., McCall, A. L., Kahn, A. F., Dhindsa, J. S., Strickland, L. M., Spada, A. R. L., & ElMallah, M. K. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048893 · Cited by 22
Malaspina, A., Ngoh, S. F. A., Ward, R. E., Hall, J. C. E., Tai, F. W. D., Yip, P. K., Jones, C., Jokic, N., Averill, S., Michael-Titus, A. T., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.053 · Cited by 22
Baird, M., Likhite, S. B., Vetter, T. A., Caporale, J. R., Girard, H. B., Roussel, F. S., Howard, A. E., Schwartz, M. K., Reed, A. R., Kaleem, A., et al. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101312 · Cited by 20
Glutamate pathway implication in amyotrophic lateral sclerosis: what is the signal in the noise?
Ré, D. B., Verche, V. L., Ikiz, B., Jacquier, A., & Przedborski, S. (2010) · Journal of Receptor Ligand and Channel Research · doi:10.2147/jrlcr.s6504 · Cited by 20
Islam, R., Kumimoto, E. L., Bao, H., & Zhang, B. (2012) · F1000Research · doi:10.12688/f1000research.1-47.v1 · Cited by 20
Schram, S., Chuang, D., Schmidt, G., Piponov, H., Helder, C. W., Kerns, J. M., Gonzalez, M. H., Song, F., & Loeb, J. A. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.12.020 · Cited by 19
Norante, R. P., Peggion, C., Rossi, D., Martorana, F., Mario, A. D., Lia, A., Massimino, M. L., & Bertoli, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205151 · Cited by 19
Rojas, P., Ramirez, A. I., Cadena, M., Fernández‐Albarral, J. A., Salobrar‐García, E., López‐Cuenca, I., Santos‐García, I., de Lago, E., Urcelay-Segura, J. L., Ramirez, J. M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041663 · Cited by 19
A perspective on stem cell modeling of amyotrophic lateral sclerosis
de Boer, A. S., & Eggan, K. C. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1093712 · Cited by 19
Nefussy, B., & Drory, V. E. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0027-0 · Cited by 18
Mesenchymal Stem Cells as Trojan Horses for GDNF Delivery in ALS
Kaspar, B. K. (2008) · Molecular Therapy · doi:10.1038/mt.2008.216 · Cited by 17
ALS, a cellular whodunit on motor neuron degeneration
Karagiannis, P., & Inoue, H. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103524 · Cited by 17
Glial phagocytosis for synapse and toxic proteins in neurodegenerative diseases
Choi, Y., & Chung, W. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00870-9 · Cited by 16
Westerhaus, A., Joseph, T., Meyers, A. J., Jang, Y., Na, C. H., Cave, C., & Sockanathan, S. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01376-x · Cited by 15
Tsuboguchi, S., Nakamura, Y., Ishihara, T., Kato, T., Sato, T., Koyama, A., Mori, H., Koike, Y. M., Onodera, O., & Ueno, M. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02615-8 · Cited by 15
Rochat, C., Bernard‐Marissal, N., Källstig, E., Pradervand, S., Perrin, F. E., Aebischer, P., Raoul, C., & Schneider, B. L. (2022) · Glia · doi:10.1002/glia.24140 · Cited by 15
Caioli, S., Pieri, M., Antonini, A., Guglielmotti, A., Severini, C., & Zona, C. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.045 · Cited by 15
Differential gene expression in the axotomized facial motor nucleus of presymptomatic SOD1 mice
Mesnard, N. A., Sanders, V. M., & Jones, K. J. (2011) · The Journal of Comparative Neurology · doi:10.1002/cne.22718 · Cited by 14
Burlando, B., Milanese, M., Giordano, G., Bonifacino, T., Ravera, S., Blanchini, F., & Bonanno, G. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244234 · Cited by 14
Therapeutic Targets in Amyotrophic Lateral Sclerosis: Focus on Ion Channels and Skeletal Muscle
Tarantino, N., Canfora, I., Camerino, G. M., & Pierno, S. (2022) · Cells · doi:10.3390/cells11030415 · Cited by 14
Thonhoff, J. R., Gao, J., Dunn, T. J., Ojeda, L. D., & Wu, P. (2012) · Europe PMC (PubMed Central) · Cited by 14
Peters, O. M., & Brown, R. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00026-5 · Cited by 12
Christoforidou, E., Moody, L., Joilin, G., Simoes, F. A., Gordon, D., Talbot, K., & Hafezparast, M. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.050638 · Cited by 12
Smith, K. S., Rush, R. A., & Rogers, M. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23763 · Cited by 12
Quo vadis motor neuron disease?
Balendra, R., & Patani, R. (2016) · World Journal of Methodology · doi:10.5662/wjm.v6.i1.56 · Cited by 12
Hałoń, M., Sielicka-Dudzin, A., Woźniak, M., Ziółkowski, W., Nyka, W. M., Herbik, M., Grieb, P., Figarski, A., & Antosiewicz, J. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.08.014 · Cited by 12
Amyotrophic lateral sclerosis: applications of stem cells – an update
Cova, L., & Silani, V. (2010) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s8662 · Cited by 12
Molecular hydrogen therapy: A “democratic” emerging strategy against aging and age-related diseases
Brandi, G., Delbaldo, C., Deserti, M., Relli, V., Rimedio, S., Palloni, A., Deiana, C., Saccoccio, G., Ingenito, R., & Tavolari, S. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102802 · Cited by 11
Glial Cells as Key Mediators in the Pathophysiology of Neurodegenerative Diseases
Bogus, K., Marchesi, N., Campagnoli, L. I. M., Pascale, A., & Pałasz, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020884 · Cited by 11
Loss of CREST leads to neuroinflammatory responses and ALS-like motor defects in mice
Cheng, C., Yang, K., Wu, X., Zhang, Y., Shan, S., Gitler, A. D., Ghosh, A., & Qiu, Z. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0152-1 · Cited by 11
Strickland, M. R., Ibanez, K. R., Yaroshenko, M., Ceballos‐Diaz, C., Borchelt, D., & Chakrabarty, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-77564-3 · Cited by 11
Metadata
- Authors
- Yamanaka, K., Boillee, S., Roberts, E. A., Garcia, M. L., McAlonis-Downes, M., Mikse, O. R., Cleveland, D. W., & Goldstein, L. S. B.
- Affiliations
- RIKEN Center for Brain Science (JP)
- *Ludwig Institute for Cancer Research and Department of Medicine and Neuroscience, University of California at San Diego, La Jolla, CA 92093;
- Howard Hughes Medical Institute (US)
- University of California San Diego (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-05-27
- Volume
- 105
- Issue
- 21
- Pages
- 7594-7599
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2396671
- OpenAlex
- W2027047473
- Cited by
- 309
- References
- 29
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 10 · 2023: 13 · 2022: 21 · 2021: 12 · 2020: 18 · 2019: 15 · 2018: 25 · 2017: 10 · 2016: 14 · 2015: 22 · 2014: 20 · 2013: 25 · 2012: 30
- FWCI
- 13.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Muscular Dystrophy Association
- Johns Hopkins University
- Uehara Memorial Foundation
- Ludwig Institute for Cancer Research
- Institut National de la Santé et de la Recherche Médicale
- Ministry of Education, Culture, Sports, Science and Technology
- National Institutes of Health
- U.S. Public Health Service (P30 NSO47101)
- Japan Society for the Promotion of Science (19591021, 27036, 19044048)
- National Institute of Neurological Disorders and Stroke (NS 27036, P30NS047101, R37NS027036, R01NS027036)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- amyotrophic lateral sclerosis, SOD1 mutations, familial ALS, motor neuron degeneration, oligodendrocytes, chimeric mice, disease initiation
- MeSH terms
- Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Genes, Dominant, Mice, Transgenic, Motor Neurons, Mutation, Oligodendroglia, Superoxide Dismutase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.